Sign in

CIK 0002012593

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Rapport Therapeutics, Inc.

Sign in to watch
Ticker
RAPP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880724208
Phone
+1 857-321-8020
Business address
99 HIGH STREET, SUITE 2100, BOSTON, MA, 02110
Former names
Rapport Therapeutics, Inc.
Open-market buys, last 90 days
$22,023,904
in 7 filings
Open-market sales, last 90 days
$4,470,180
in 7 filings, $4.5M under 10b5-1 plans

Net +$17,553,724. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-30 Gault Cheryl Chief Operating Officer Sale 10b5-1 −7,161 $28.04 $201K 162,753
2026-03-30 Gault Cheryl Chief Operating Officer Sale 10b5-1 −2,839 $28.55 $81K 159,914
2026-03-25 Yeleswaram Krishnaswamy Chief Development Officer Sale 10b5-1 −10,115 $29.99 $303K 286,876
2026-03-05 Gault Cheryl Chief Operating Officer Sale −2,014 $28.93 $58K 169,914
2026-02-18 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −3,552 $29.05 $103K 558,528
2026-02-18 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −2,281 $29.80 $68K 556,247
2026-02-18 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −2,983 $29.04 $87K 22,829
2026-02-18 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −2,100 $29.80 $63K 20,729
2026-02-17 Bredt David Chief Scientific Officer Sale 10b5-1 −900 $28.02 $25K 394,675
2026-02-17 Bredt David Chief Scientific Officer Sale 10b5-1 −5,400 $28.95 $156K 389,275
2026-02-17 Bredt David Chief Scientific Officer Sale 10b5-1 −2,200 $29.59 $65K 387,075
2026-01-20 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −5,833 $26.12 $152K 562,080
2026-01-20 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −5,083 $26.11 $133K 25,812
2026-01-15 Bredt David Chief Scientific Officer Sale 10b5-1 −8,300 $26.83 $223K 395,775
2026-01-15 Bredt David Chief Scientific Officer Sale 10b5-1 −200 $27.40 $5K 395,575
2025-12-31 Bredt David Chief Scientific Officer Sale −6,567 $30.05 $197K 404,075
2025-12-31 Yeleswaram Krishnaswamy Chief Development Officer Sale −2,840 $30.05 $85K 296,991
2025-12-17 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −2,441 $28.84 $70K 571,305
2025-12-17 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −2,792 $30.04 $84K 568,513
2025-12-17 Ceesay Abraham Chief Executive Officer Sale 10b5-1 −600 $31.04 $19K 567,913

Page 3 of 5 · 92 trades